America’s drug-pricing reset will reverberate far beyond Washington
Countries like Canada could find themselves navigating tighter negotiations and slower access to new therapies.
The United States’ renewed push toward “most favoured nation” drug pricing is widely framed as a domestic cost-of-living measure, while also serving as a politically salient policy signal ahead of the midterm elections. That framing understates its significance. What i...
Get Weekend Point of View Newsletter
Top Canadian political and policy opinion and analysis. Saturdays and Sundays. Weekends.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
